Jeffrey Dierks Harmony Biosciences Holdings, Inc. (HRMY) insider trading activity

Jeffrey Dierks is CHIEF COMMERCIAL OFFICER of Harmony Biosciences Holdings, Inc.. Currently has a direct ownership of 0 shares of HRMY, which is worth approximately $0. The most recent transaction as insider was on Jan 21, 2025, when has been sold 1,123 shares (Common Stock) at a price of $40.0 per share, resulting in proceeds of $44,920. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Jeffrey Dierks Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 21 2025	SELL Open market or private sale	$44,920 $40.0 p/Share	1,123 Reduced 100.0%	0 Common Stock
Jan 21 2025	BUY Exercise of conversion of derivative security	$37,553 $33.44 p/Share	1,123 Added 50.0%	1,123 Common Stock
Jan 16 2025	SELL Open market or private sale	$1,102,659 $37.41 p/Share	29,475 Reduced 100.0%	0 Common Stock
Jan 16 2025	BUY Exercise of conversion of derivative security	$985,643 $33.44 p/Share	29,475 Added 50.0%	29,475 Common Stock
Jan 15 2025	SELL Open market or private sale	$388,864 $37.01 p/Share	10,507 Reduced 100.0%	0 Common Stock
Jan 15 2025	BUY Exercise of conversion of derivative security	$351,354 $33.44 p/Share	10,507 Added 50.0%	10,507 Common Stock
Jan 13 2025	SELL Open market or private sale	$265,947 $37.04 p/Share	7,180 Reduced 100.0%	0 Common Stock
Jan 13 2025	BUY Exercise of conversion of derivative security	$240,099 $33.44 p/Share	7,180 Added 50.0%	7,180 Common Stock
Oct 29 2024	SELL Open market or private sale	$869,943 $40.47 p/Share	21,496 Reduced 100.0%	0 Common Stock
Oct 29 2024	BUY Exercise of conversion of derivative security	$515,904 $24.0 p/Share	21,496 Added 50.0%	21,496 Common Stock
Oct 03 2024	SELL Open market or private sale	$1,284,492 $35.33 p/Share	36,357 Reduced 100.0%	0 Common Stock
Oct 01 2024	SELL Open market or private sale	$16,076 $40.19 p/Share	400 Reduced 100.0%	0 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$9,600 $24.0 p/Share	400 Added 50.0%	400 Common Stock
Sep 30 2024	SELL Payment of exercise price or tax liability	$945,720 $40.0 p/Share	23,643 Reduced 39.41%	36,357 Common Stock
Sep 30 2024	SELL Open market or private sale	$1,434,915 $40.03 p/Share	35,846 Reduced 100.0%	0 Common Stock
Sep 30 2024	BUY Exercise of conversion of derivative security	-	60,000 Added 50.0%	60,000 Common Stock
Sep 30 2024	BUY Exercise of conversion of derivative security	$860,304 $24.0 p/Share	35,846 Added 50.0%	35,846 Common Stock
Sep 27 2024	SELL Open market or private sale	$8,009 $40.05 p/Share	200 Reduced 100.0%	0 Common Stock
Sep 27 2024	BUY Exercise of conversion of derivative security	$4,800 $24.0 p/Share	200 Added 50.0%	200 Common Stock
Mar 15 2024	SELL Open market or private sale	$383,328 $32.0 p/Share	11,979 Reduced 100.0%	0 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	$98,467 $8.22 p/Share	11,979 Added 50.0%	11,979 Common Stock
Mar 08 2024	SELL Open market or private sale	$6,208 $32.0 p/Share	194 Reduced 100.0%	0 Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	$1,594 $8.22 p/Share	194 Added 50.0%	194 Common Stock
Oct 03 2022	SELL Open market or private sale	$547,298 $44.96 p/Share	12,173 Reduced 100.0%	0 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$100,062 $8.22 p/Share	12,173 Added 50.0%	12,173 Common Stock

Jeffrey Dierks

CHIEF COMMERCIAL OFFICER

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRMY shares.

Notify only if

Value

Insider Trading

Get notified when an Harmony Biosciences Holdings, Inc. insider buys or sells HRMY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Harmony Biosciences Holdings, Inc.

Track Activities on HRMY

Account